Evidence map›Paper›PMID 28702805›Full record

ArticleJournal of molecular modeling2017

The functionalization of carbon nanotubes to enhance the efficacy of the anticancer drug paclitaxel: a molecular dynamics simulation study.

Hassan Hashemzadeh, Heidar Raissi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 66 citations in OpenAlex.

  1. The pharmaceutical applications of palm kernel oil: innovations in dermatological therapies.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  2. Review
  3. Functionalized MoSScientific reports · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hassan HashemzadehDepartment of Chemistry, University of Birjand, Birjand, Iran. hashemzade_h@birjand.ac.ir.
Heidar RaissiDepartment of Chemistry, University of Birjand, Birjand, Iran.
University of Birjand · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon nanotubes (CNTs) are widely used in drug delivery systems (DDSs) due to their unique chemical and physical properties. Investigation of interactions between biomolecules and CNTs is an interesting and important subject in biological applications. In this study, we used molecular dynamics (MD) simulation to investigate the adsorption mechanism of the anticancer drug paclitaxel (PTX) on pristine and functionalized CNTs (f-CNT) in aqueous solutions. Our theoretical results show that PTX can be adsorbed on sidewalls of CNT in different methods. In the case of f-CNTs, PTX can be adsorbed on the functional groups due to the existence of polar interactions. These interactions in the CNT functionalized with polyethylene glycol (PEG), are more than the other investigated systems. Furthermore, it was found that the solubility of CNTs in aqueous solution is increased by functionalization. This is related to the intermolecular hydrogen bonds between functional groups and solvent molecules. The PEG group has the greatest effect on the solubility of the CNT in aqueous solution due to more polar interactions.

Indexed as

Drug Delivery SystemsMolecular Dynamics SimulationAdsorptionAnimalsAntineoplastic AgentsHumansHydrophobic and Hydrophilic InteractionsNanotubes, CarbonPaclitaxelTreatment OutcomeAntineoplastic AgentsNanotubes, CarbonPaclitaxelDrug delivery systemFunctionalized carbon nanotubeMolecular dynamics simulationPaclitaxel anticancer drugSolubility carbon nanotube

Identifiers

PMID28702805
OpenAlexW2734901844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.